UMRX has $1.50 in cash and has been beaten down on very low volume over the last 3 weeks. They are presentation at ASH in early December. This cancer play should see a bounce to 85c+ then a continuation move above $1. UMRX also has news on its drug trial upcoming. ASLN is up 100%...